Full Press Release Details
GAITHERSBURG, Md., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will be hosting an analyst and investor day on November 21, 2019 from 8:00 AM EST to 2:00 PM EST in New York City. This event is designed for sellside research analysts and institutional investors and requires registration for onsite participants, as space is limited.
To register for onsite participation at the event or for more information, please contact Robert Burrows, IRO for Emergent BioSolutions at burrowsr@ebsi.com or (240) 631-3280.
Emergent’s senior management will provide a detailed overview of the company’s 2020-2024 Growth Strategy. Presenters include President and CEO, Robert G. Kramer; EVP, Business Operations, Adam Havey; EVP, Corporate Development and General Counsel, Atul Saran; EVP and CFO, Richard Lindahl; EVP, Manufacturing and Technical Operations, Sean Kirk; and the heads of Emergent’s four business units.
Lunch will be provided onsite following completion of the formal portion of the event.
A live audio-only webcast of the formal portion of the event as well as presentation materials will be available on the Investor Relations homepage of the company’s website at https://investors.emergentbiosolutions.com/. The audio and accompanying presentations will be archived on the company’s website after completion of the event.
About Emergent BioSolutions
Vice President, Investor Relations
Vice President, Corporate Communications